Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment
In conclusion, NKG2D-based CAR-T cells have potent in vivo and in vitro anti-tumor activities against gastric cancer and could be a new paradigm for patients with gastric cancer, either used alone or combined with chemotherapy.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Drugs & Pharmacology | Gastric (Stomach) Cancer | Gastroenterology | Hematology | Study